Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 8, Number 2—February 2002

Epidemiology of Burkholderia cepacia Complex in Patients with Cystic Fibrosis, Canada

David P. Speert*, Deborah Henry*, Peter Vandamme†, Mary Corey‡, and Eshwar Mahenthiralingam*
Author affiliations: *University of British Columbia and Children’s and Women’s Health Centre of British Columbia, Vancouver, British Columbia, Canada; †University of Ghent, Ghent, Belgium; ‡The Hospital for Sick Children, Toronto, Ontario, Canada

Main Article

Table 2

Genomovar or species of Burkholderia cepacia complex or phenotypically similar isolates from cystic fibrosis patients in Canada

Species or genomovar No. of patients infected with species or genomovara Percentage of patients (%)
Genomovar I 1 0.2
Burkholderia multivorans (genomovar II) 43 9.3
Genomovar III 369 80.0
Burkholderia stabilis (genomovar IV) 17 3.8
Burkholderia vietnamiensis (genomovar V) 7 1.6
Burkholderia cepacia complex (not genomovar I-VII) 8 1.8
Burkholderia fungorum 1 0.2
Burkholderia gladioli 5 1.1
Ralstonia pickettii 5 1.1
Pandoraea spp.
Total 461

aSome patients were counted twice if two or more different strains were recovered.

Main Article

Page created: April 18, 2012
Page updated: April 18, 2012
Page reviewed: April 18, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.